RecruitingNot ApplicableNCT06263907

Stellate Ganglion Block for Prevention of Post Mastectomy Depression

Preemptive Efficacy of Stellate Ganglion Block for Prevention of Post Mastectomy Depression


Sponsor

Mansoura University

Enrollment

140 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Complications after mastectomy include chronic pain and depression.


Eligibility

Sex: FEMALEMin Age: 21 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a nerve block procedure called a stellate ganglion block — an injection in the neck that briefly calms part of the nervous system — can help prevent depression after mastectomy (surgical removal of the breast for cancer). **You may be eligible if...** - You are a female patient aged 18 to 65 - You have breast cancer in one breast and are scheduled for a unilateral modified radical mastectomy - You are otherwise in good general health (ASA class I or II) **You may NOT be eligible if...** - You are pregnant - You have a neurological or neuromuscular disease - You have an allergy to local anesthetics - You have neck abnormalities, prior neck surgery, or certain heart/lung conditions - You have a pre-existing history of depression, bipolar disorder, or other psychiatric disorders - You are currently taking pain medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREStellate gangalion block

The efficacy of Preoperative ipsilateral stellate gangalion block on the occurrence of postmastectomy depression and pain compared with no block


Locations(1)

Maha

Al Mansurah, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06263907


Related Trials